Resistance to apoptotic cell death in a drug resistant T cell leukaemia cell line

Leukemia

Volumn 10, Issue 3, 1996, Pages 447-455

  Geyp, M ^a   Ireland, C M ^a   Pittman, S M ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Apoptosis; Drug resistance; T cell leukaemia; Tubulin; Vincristine

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; GLYCOPROTEIN P; PROTEIN BCL 2; PROTEIN P53; VINCRISTINE;

ACETYLATION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA CLEAVAGE; HUMAN; HUMAN CELL; MICROTUBULE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; T CELL LEUKEMIA;

EID: 0029968426     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Kerr JR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
2. Wyllie AH. Cell death: a new classification separating apoptosis from necrosis. In: Bowden ID, Lockshin RA (eds). Cell Death in Biology and Pathology. Chapman and Hall. London, 1980, pp 9-34.
3. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytology 1980; 68: 251-306.
4. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth development and differentiation of both tumour and normal cells. Anticancer Res 1990; 10: 1153-1160.
5. Golstein P, Ojcius DM, Young D-E. Cell death mechanisms and the immune system. Immunol Rev 1991; 121: 29-65.
6. Bursch W, Oberhammer F, Schulte-Herman R. Cell death by apoptosis and its protective role against disease. Trends Pharm Sci 1992; 13: 245-251.
7. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease. Nature 1980; 284: 555-556.
8. Baxter GD, Collins RJ, Harman BV, Kumar S, Prentice RL, Smith PJ, Lavin MF. Cell death by apoptosis in acute leukaemia. J Pathol 1989; 158: 123-129.
9. Boobis AR, Fawthrop DJ, Davies DS. Mechanisms of cell toxicity Curr Opin Cell Biol 1990; 2: 231-237.
10. Bansal N, Houle A, Melnykovych G. Apoptosis: mode of cell death induced in T cell leukemia lines by dexamethasone and other agents. FASEB J 1991; 5: 211-216.
11. Umansky SR. Apoptotic process in the radiation-induced death of lymphocytes. In: Tomei LD, Cope FO (eds). Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor Laboratory Press: New York, 1991, 193-208.
12. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastas Rev 1992; 11: 121-139.
13. Warters RL. Radiation-induced apoptosis in a murine T cell hybridoma. Cancer Res 1992; 52: 883-890.
14. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M. Apoptotic cell death in epithelial cells: cleavage of DNA to 300 and/or 50-kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993; 9: 3679-3684.
15. Askew DS, Ashmun RA, Simmons BC, Clevland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-1922.
16. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
17. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992; 257: 212-214.
18. Thulasi R, Harbour DV, Thompson EB. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J Biol Chem 1993; 268: 18306-18312.
19. Milner AE, Grand RJA, Waters CM, Gregory CD. Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene 1993; 8: 3385-3391.
20. Evan GI, Littlewood TD. The role of c-myc in cell growth. Curr Opin Genet Devel 1993; 3: 44-49
21. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs I, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-347.
22. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
23. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. P53 is required for radiation-induced apoptosis in mouse thymocytes Nature 1993; 362: 847-849.
24. Lowe SW, Ruley HE, Jacks T, Housman DE. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-967.
25. Nuñez G, London L, Hockenberry D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
26. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992; 259: 1955-1957.
27. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151-157.
28. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365-368.
29. Jacobson MD, Burne JF, Raff MC. Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J 1994; 13: 1899-1910.
30. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992; 359: 554-556.
31. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552-554.
32. Wagner AJ, Small MB, Hay N. Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Molec Cell Biol 1993; 13: 2432-2440.
33. Wang Y, Szekely L, Okan I, Klein G, Wiman KG. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T cell lymphoma line. Oncogene 1993; 8: 3427-3431.
34. Chiou S-K, Rao L, White E. Bcl-2 blocks p53-dependent apoptosis. Molec Cell Biol 1994; 14: 2556-2563.
35. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-442.
36. Walton MI, Whysong D, O'Connor PM, Hockenberry D, Korsmeyer SJ, Kohn KW. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 1993; 53: 1853-1861.
37. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA. Bcl-2 modulation of apoptosis induced by anticancer drugs - resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 1993; 53: 3321-3326.
38. Kitada S, Takayama S, Deriel K, Tanaka S, Reed JC. Reversal of chemoresistance of lymphoma cells by antisense mediated reduction of bcl-2 gene expression. Antisense Res Devel 1994; 4: 71-79.
39. Hickman JA, Potten CS, Merritt AJ, Fisher TC. Apoptosis and chemotherapy. Philos Trans R Soc London Series B - Biol Sci 1994; 345: 319-325.
40. Kerbel RS, Kobayashi H, Graham CH. Intrinsic or acquired drug resistance and metastasis - are they linked phenotypes? J Cell Chem 1994; 56: 37-47.
41. Maung ZT, Maclean FR, Reid MM, Pearson ADJ, Proctor SJ, Hamilton PJ, Hall AG. The relationship between bcl-2 expression and response to chemotherapy in acute leukemia. Br J Haematol 1994; 88: 105-109.
42. Pittman S, Strickland D, Ireland C. Polymerization of tubulin in apoptotic cells is not cell cycle dependent. Exp Cell Res 1994; 215: 263-272.
43. Pittman S, Geyp M, Tynan S, Gramacho C, Strickland D, Fraser MJ, Ireland CM. Tubulin in apoptotic cells. In: Lavin M, Watters D (eds). Cell Death: The Cellular and Molecular Basis of Apoptosis. Harwood Academic: New York, 1993, pp 315-325.
44. Ireland C, Pittman S. Tubulin alterations in taxol-induced apoptosis parallel those seen with other drugs. Biochem Pharmacol 1994; 49: 1491-1499.
45. Avila J. Microtubule functions. Life Sci 1992; 50: 327-334.
46. Roychowdhury S, Wang N, Rasenick MM. G protein binding and G protein activation by nucleotide transfer involve distinct domains on tubulin: regulation of signal transduction by cytoskeletal elements. Biochemistry 1993; 32: 4955-4961.
47. Joshi H, Cleveland D. Diversity among tubulin subtypes: toward what functional end? Cell Motil Cytoskeleton 1990; 16: 159-163.
48. Murphy D. Function of tubulin isoforms. Curr Opin Cell Biol 1991; 3: 43-51.
49. Mandelkow E, Mandelkow E-M. Microtubular structure and tubulin polymerization. Curr Opin Cell Biol 1990; 2: 3-9.
50. LeDizet M, Piperno G. Cytoplasmic microtubules containing acetylated α-tubulin in Clamydomonas reinhardtii: spatial arrangement and properties. J Cell Biol 1986; 103: 13-22.
51. Schulze E, Asai DJ, Bulinski JC, Kirschner M. Post-translational modification and microtubule stability. J Cell Biol 1987; 105: 2167-2177.
52. Khawaja S, Gunderson GG, Bulinski JC. Enhanced stability of microtubules enriched in detyrosinated tubulin is not a direct function of detyrosination levels. J Cell Biol 1988; 106: 141-189.
53. Webster DR, Borisy GG. Microtubules are acetylated in domains that turn over slowly. J Cell Science 1989; 92: 57-65.
54. Webster DR, Wehland J, Weber K, Borisy GG. Detyrosination of alpha tubulin does not stabilize microtubules in vivo. J Cell Biol 1990; 111: 113-122.
55. Idriss H, Stammers DK, Ross CK, Burns RG. The dynamic instability of microtubules is not modulated by α-tubulin tyrosination. Cell Motil Cytoskeleton 1991; 20: 30-37.
56. Schibler MJ, Huang B. The CoIR4 and CoIR15 beta tubulin mutations in Clamydomonas reinhardtii confer altered sensitivities to microtubule inhibitors and herbicides enhancing microtubule stability. J Cell Biol 1991; 113: 605-614.
57. Harrington EA, Fanidi A, Evan GI. Oncogenes and cell death. Curr Opin Genet Devel 1994; 4: 120-129.
58. Frankfurt OS, Seckinger D, Sugarbaker EV. Apoptosis and growth inhibition in sensitive and resistant leukemic cells treated with anticancer drugs. Int J Oncol 1994; 4: 481-489.
59. Frankfurt OS, Seckinger D, Sugarbaker EV. Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic response. Int J Cancer 1994; 59: 217-224.
60. Kataoka S, Naito M, Tomida A, Tsuruo T. Resistance to antitumor agent induced apoptosis in a mutant of human myeloid leukemia U937 cells. Exp Cell Res 1994; 215: 199-205.
61. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965; 18: 522-529.
62. Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to vinca alkaloids independent of P-glycoprotein. Cancer Res 1989; 49: 5281-5287.
63. Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T cell line in serum free medium. Proc Natl Acad Sci USA 1993; 90: 4708-4712.
64. Pittman SM, Kavallaris M, Stewart BW. Karyotypic analysis of CCRF-CEM and drug-resistant cell lines with stable and unstable ploidy Cancer Genet Cytogenet 1993; 66: 54-62.
65. Taylor IW, Hodson PJ. Cell cycle regulation by environmental pH. J Cell Physiol 1984; 121: 517-525.
66. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223-254.
67. Pollice AA, McCoy JP, Shackney SE, Smith CA, Argawal J, Burholt DR, Janocko LE, Hornicek FJ, Singh SG, Hartsock RJ. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry 1992; 13: 432-444.
68. Bissonette RP, Shi Y, Mahboubi A, Glynn JM, Green DR. C-myc and apoptosis. In: Tomei LD, Cope FO (eds). Apoptosis II: The Molecular Basis of Apoptosis in Disease. Cold Spring Harbor Laboratory Press: New York, 1994, pp 327-356.
69. Cotter TG, Glynn JM, Echeverri F, Green DR. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res 1992; 12: 773-780.
70. Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T cell lines. Molec Cell Biol 1990; 10: 5502-5509.
71. Murphy DB. Functions of tubulin isoforms. Curr Opin Cell Biol 1991; 3: 43-51.